Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients
- 31 October 2004
- journal article
- case report
- Published by Elsevier in Acta Tropica
- Vol. 92 (2), 127-132
- https://doi.org/10.1016/j.actatropica.2004.06.006
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy, safety and cost-effectiveness of Amphotericin B Lipid Complex (ABLC): a review of the literatureCurrent Medical Research and Opinion, 2004
- New PCR Assay Using Glucose-6-Phosphate Dehydrogenase for Identification of Leishmania SpeciesJournal of Clinical Microbiology, 2003
- Activity of azithromycin against Leishmania major in vitro and in vivo.The American Journal of Tropical Medicine and Hygiene, 2002
- Mucocutaneous leishmaniasis associated with HIV infection treated successfully with liposomal amphotericin B (AmBisome)Journal of Antimicrobial Chemotherapy, 2000
- American cutaneous leishmaniasis associated with HIV infection: report of four casesJournal of the European Academy of Dermatology and Venereology, 1998
- Leishmania and human immunodeficiency virus coinfection: the first 10 yearsClinical Microbiology Reviews, 1997
- Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 YearsClinical Infectious Diseases, 1997
- VISCERAL LEISHMANIASIS WITH CUTANEOUS AND RECTAL DISSEMINATION DUE TO LEISHMANIA BRAZILIENSIS IN ACQUIRED IMMUNODEEICIENCY SYNDROME (AIDS)International Journal of Dermatology, 1995
- A Review of the Geographic Distribution and Epidemiology of Leishmaniasis in the New WorldThe American Journal of Tropical Medicine and Hygiene, 1989
- Disseminated American cutaneous leishmaniasis in a patient with AIDSMemórias do Instituto Oswaldo Cruz, 1987